Smith Thornton Advisors’s Eli Lilly LLY Stock Holding History

Smith Thornton Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Buy	1,189 +288	+32%	+$294K	0.62%	45
2026 Q1	$828K	Buy	901 +1	+0.1%	+$1.01K	0.42%	60
2025 Q4	$968K	Sell	900 -6	-0.7%	-$5.74K	0.49%	54
2025 Q3	$692K	Buy	906 +5	+0.6%	+$3.72K	0.36%	67
2025 Q2	$703K	Buy	901 +70	+8%	+$54.4K	0.4%	62
2025 Q1	$686K	Buy	831 +37	+5%	+$30.8K	0.43%	60
2024 Q4	$613K	Buy	794 +335	+73%	+$277K	0.39%	69
2024 Q3	$407K	Buy	459 +3	+0.7%	+$2.7K	0.27%	92
2024 Q2	$413K	Buy	+456	New	+$365K	0.3%	84

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Smith Thornton Advisors's LLY Position: Q2 2026 in Review

Smith Thornton Advisors increased its Eli Lilly (LLY) stake by 32% in Q2 2026, buying an estimated $294K and bringing the position to 1,189 shares worth $1.4M. The position accounts for 0.62% of the portfolio, ranked #45.

Smith Thornton Advisors first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Smith Thornton Advisors held 1,189 shares of Eli Lilly worth $1.4M as of Q2 2026.
Smith Thornton Advisors bought 288 Eli Lilly shares in Q2 2026, an estimated $294K.
Eli Lilly made up 0.62% of Smith Thornton Advisors's portfolio in Q2 2026, its #45 holding.
Smith Thornton Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Smith Thornton Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.